IL2 and diabetes mellitus: In a similar way to that reported in in vitro experiments, after in vivo administration of IL-2/anti-IL-2 complex therapy a weak expansion of Tregs and suboptimal protection against diabetes was observed in NOD mice (48), indicating that the sole administration of IL-2 fails to completely raise Treg cell numbers in NOD mice.